Use of a 5-HT6 agonist for the treatment and prevention of neurodegenerative disorders

Details for Australian Patent Application No. 2005316675 (hide)

Owner Wyeth

Inventors Pong, Kevin; Zaleska, Margaret Maria; Schechter, Lee Erwin

Agent Davies Collison Cave

Pub. Number AU-A-2005316675

PCT Pub. Number WO2006/065710

Priority 60/635,766 14.12.04 US

Filing date 12 December 2005

Wipo publication date 22 June 2006

International Classifications

A61K 31/00 (2006.01)

A61K 31/4045 (2006.01)

A61K 31/429 (2006.01) - condensed with heterocyclic ring systems

A61K 31/437 (2006.01)

A61P 25/16 (2006.01) Drugs for disorders of the nervous system

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

Event Publications

5 July 2007 PCT application entered the National Phase

  PCT publication WO2006/065710 Priority application(s): WO2006/065710

3 December 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005316676-Octahydropyrano[3,4-c]pyrrole tachykinin receptor antagonists

2005316671-N-biaryl and N-arylheteroaryl 2-substituted piperazine derivatives as modulators of the 5HT2C receptor useful for the treatment of disorders related thereto